Florida Department of HealthEPI UPDATE

A weekly publication by the Bureau of Epidemiology

March 2, 2001

"The reason for collecting, analyzing and disseminating information on a disease is to control that disease. Collection and analysis should not be allowed to consume resources if action does not follow."

--Foege WH et al. Int. J of Epidemiology 1976; 5:29-37.

Richard S. Hopkins, MD, MSPH, Bureau Chief, State Epidemiologist

Don Ward, Surveillance Section Administrator, Epi Update Managing Editor

Jason Glisson, BS, Epi Editorial Assistant

Bureau of Epidemiology Frequent Contributors:

Steven Wiersma, MD, MPH,

Deputy State Epidemiologist

Jodi Baldy, MPH,

Biological Scientist IV

Ursula E. Bauer, PhD,

Chronic Disease Epidemiologist

Lisa Conti, DVM, MPH,

State Public Health Veterinarian

Regional Epidemiologists:

Dolly Katz, PhD, MPH,

SE Florida

Roger Sanderson, RN, MA,

SW Florida

Carina Blackmore, MS Vet. Med., PhD,

NE Florida Carina Blackmore, MS Vet. Med., PhD,

Zuber Mulla, MSPH,

Central Florida Carina Blackmore, MS Vet. Med., PhD,

Please print out this material and share with epidemiology staff, county health department directors, administrators, medical directors, nursing directors, environmental health directors and others with an interest in information of this type. Thank you.

The Bureau of Epidemiology is available 24 hours a day, 7 days a week for consultation at our main number (SunCom 205-4401 or 850/245-4401) PLEASE NOTE: Consultation after 5 p.m. & on weekends is intended for emergencies.

The Department of Health has a home on the World Wide Web at http://www.doh.state.fl.us

In this issue:

1. National Infant Immunization Week

2. Influenza Surveillance Update

3. Weekly Disease Table


 

1. National Infant Immunization Week

Henry T. Janowski, MPH, Chief, Bureau of Immunization

April 22-28, 2001 has been designated National Infant Immunization Week and, again, the Bureau of Immunization is calling upon all health care providers to assist in spreading the immunization message. Since the private medical community administers two out of every three immunizations in Florida, reaching out to these providers is an essential element of our campaign.

In 2000, Florida’s immunization coverage level for two-year-olds rose to an all-time high of 86.6 percent. National Infant Immunization Week offers an excellent opportunity for us to celebrate our successes and to reaffirm our commitment to preventive child health care through immunizations. Please work with us by:

Incorporating the immunization message into an organization-wide presentation, newsletter, or other mode of communication.

Emphasizing the importance of adhering to the Recommended Childhood Immunization Schedule-a practice that not only prevents the spread of vaccine-preventable disease, but also serves as a vehicle to bring children into a "medical home" for routine preventative health care. (A copy of the schedule can be found on the Centers for Disease Control and Prevention’s (CDC) Web site at http://www.cdc.gov/nip/recs/child-schedule.PDF

Encourage implementation of the Standards of Pediatric Immunization Practices (see attached).

If you have any questions regarding the campaign, please contact Linda Zeigler, Bureau of Immunization, at (850) 245-4342 or SunCom 205-4342.

immunization standards word doc

 

2. Influenza Surveillance Update

Carina Blackmore, MS, Vet. Med., PhD, NE Florida

(Week ending February 17, 2001-Week 7)

Florida: Florida is one of 14 states still reporting low levels of influenza activity. Overall, two percent of 14,085 patients seeking care by reporting physicians in the influenza sentinel surveillance met the case definition for ILI during week 7. Two isolates of influenza were reported to our laboratory database this week: influenza B was reported from Duval and Franklin counties. Since October 1, of 2000,118 influenza isolations have been reported to the state health office: 40 influenza A (H1N1) isolates from Broward, Charlotte, Dade, Duval, Escambia, Hillsborough, Indian River, Lake, Leon, Nassau, Orange and Polk counties, one influenza A (H3N2) from Duval county, 16 untyped influenza A isolates from Alachua, Clay, Columbia, Hillsborough, Orange, Palm Beach and Pinellas counties) and 61 influenza B isolates from Brevard, Broward, Charlotte, Clay, Duval, Franklin, Hillsborough, Indian River, Leon, Levy, Orange, Palm Beach, Santa Rosa, Seminole and Volusia counties.

National report: Influenza activity appears to be declining in the United States. For the current season, the overall national percentage of respiratory specimens positive for influenza appears to have peaked at 24% at the end of January (week 4). During the past 3 seasons, the peak percentages of respiratory specimens positive for influenza viruses have ranged from 28% to 33%. For this season, the percentage of patient visits to sentinel physicians for ILI appears to have peaked at 4% in the mid to late January (weeks 3-5). During the past 3 seasons, the peak percentages for such visits ranged between 5% and 6%. During week 7, 7 states (Colorado, New Jersey, North Carolina, Oklahoma, Rhode Island, Tennessee, and Utah) state and territorial health departments reported widespread and 27 states reported regional activity during week 7. Fifteen percent of the 1,595 specimens tested in WHO and NREVSS laboratories reported 1,459 were positive for influenza. A majority of these isolates (52%) were influenza type B. The highest yield in recent weeks (weeks 5-7) was seen in from patients in the New England region where 34% tested positive for flu.

The 2000-2001 flu vaccine induces reactive antibodies against all 389-virus strains that have been antigenically characterized at CDC this year.

During week 7, the percentage of all deaths due to P&I as reported by the vital statistics offices of 122 U.S. cities was 7.8%, which is below the epidemic threshold of 8.7%

Three percent of patient visits to U.S. sentinel physicians were due to influenza-like illness (ILI). The percentage of patient visits for ILI was within baseline levels (3%) in 8 of 9 surveillance regions. Influenza activity was above baseline levels (4%) in the Pacific Region.

Between 23.2% and 35.2% of tested specimens were positive for Respiratory Syncytial Virus (RSV) this week. Twelve Florida hospital laboratories participate in this program.

 

 

3. Weekly Disease Table (Week 8)

DISEASE

1998 TO
CURRENT
WEEK #

1999 TO
CURRENT
WEEK #

2000 TO
CURRENT
WEEK #

3 YEAR
AVERAGE
TO CURRENT
WEEK #

2000
TOTAL
CASES

2001 TO
CURRENT
WEEK #

Animal Rabies

34

24

17

25

161

25

Anthrax

0

0

0

0

0

0

Botulism, foodborne

0

0

0

0

0

0

Botulism, infant

0

0

0

0

0

0

Botulism, wound

0

0

0

0

0

0

Botulism, other

0

0

0

0

0

0

Brucellosis

0

0

0

0

2

0

Campylobacteriosis

69

76

69

71.3333

1024

57

Ciguatera

0

0

0

0

14

0

Cryptosporidiosis

12

3

8

7.6667

178

12

Cyclosporiasis

0

0

0

0

9

18

Dengue Fever

0

1

0

0.3333

5

1

Diphtheria

0

0

0

0

0

0

Ehrlichiosis, human

0

0

0

0

1

0

Encephalitis, chickenpox

0

0

0

0

0

0

Encephalitis, Eastern Equine

0

0

0

0

0

0

Encephalitis, herpes

3

0

0

1

6

0

Encephalitis, influenza

0

0

0

0

1

0

Encephalitis, measles

0

0

0

0

0

0

Encephalitis, mumps

0

0

0

0

0

0

Encephalitis, other

0

1

0

0.3333

8

0

Encephalitis, St. Louis

0

0

0

0

0

0

Encephalitis, Venezuelan

0

0

0

0

0

0

Encephalitis, Western Equine

0

0

0

0

0

0

Escherichia Coli 0157:H7

2

3

3

2.6667

95

2

Escherichia Coli, other

0

1

2

1

14

1

Giardiasis

119

97

68

94.6667

1433

60

H. Influenzae Cellulitis

1

0

0

0.3333

1

0

H. Influenzae Epiglottitis

0

0

0

0

1

0

H. Influenzae Meningitis

3

2

0

1.6667

12

2

H. Influenzae Pneumonia

1

1

0

0.6667

8

6

H. Influenzae Prim.Bacteremia

6

2

3

3.6667

55

12

H. Influenzae Septic Arthritis

0

0

0

0

1

0

Hantaviris Infection

0

0

0

0

0

0

Hemolytic Uremic Syndrome

0

0

1

0.3333

16

0

Hemorrhagic Fever

0

0

0

0

0

0

Hepatitis A

69

55

50

58

589

61

Hepatitis B

26

24

34

28

508

29

Hepatitis B (+HbsAg in pregnant women)

NR

3

19

NR

475

17

Hepatitis, Perinatal Hep B

NR

0

0

NR

1

0

Hepatitis C

NR

2

2

NR

21

1

Hepatitis, Non-A, Non-B

7

0

1

2.6667

6

0

Hepatitis, Other, including unspecified

0

1

2

1

7

0

Lead Poisoning

214

187

72

157.6667

944

52

Legionellosis

8

5

7

6.6667

53

4

Leprosy

1

0

0

0.3333

4

0

Leptospirosis

0

0

0

0

2

0

Listeriosis

NR

2

2

NR

32

2

Lyme Disease

1

1

0

0.6667

52

0

Malaria

4

9

4

5.6667

86

3

Measles

1

0

0

0.3333

2

0

Meningitis, Group B Strep

1

2

0

1

21

2

Meningitis, List Monocytogenes

1

0

1

0.6667

7

0

Meningitis, Meningococcal

9

6

6

7

42

10

Meningitis, other

7

4

5

5.3333

108

4

Meningitis, Strep Pneumoniae

20

17

19

18.6667

111

12

Meningococcemia, disseminated

12

8

15

11.6667

82

10

Mercury Poisoning

0

0

1

0.3333

11

0

Mumps

2

0

0

0.6667

4

0

Neurotoxic Shellfish Poisoning

0

0

0

0

0

0

Pertussis

8

3

1

4

48

1

Plague, Bubonic

0

0

0

0

0

0

Plague, Pneumonic

0

0

0

0

0

0

Poliomyelitis

0

0

0

0

0

0

Psittacosis

0

0

0

0

3

0

Q Fever

NR

0

0

NR

0

0

Human Rabies

0

0

0

0

0

0

Rocky Mountain Spotted Fever

0

0

0

0

1

0

Rubella

0

0

0

0

2

0

Rubella, Congenital

0

0

0

0

1

0

Salmonellosis

164

178

139

160.3333

2742

152

Shigellosis

125

134

111

123.3333

1283

63

Smallpox

NR

0

0

NR

0

0

Staphylococcus Aureus (GISA/VISA)

NR

0

0

NR

0

0

Staphylococcus Aureus (GRSA/VRSA)

NR

0

0

NR

0

0

Streptococcal Disease, Invasive Group A

4

8

12

8

147

19

Streptococcus Pneumoniae, Invasive

86

52

155

97.6667

1138

147

Tetanus

0

0

0

0

1

0

Toxoplasmosis

3

0

0

1

12

0

Trichinosis

0

0

0

0

1

0

Tularemia

NR

0

0

NR

0

0

Typhoid Fever

4

4

0

2.6667

12

1

Vibrio Alginolyticus

0

2

1

1

15

0

Vibrio Cholerae Type 01

0

0

0

0

0

0

Vibrio Cholerae Non-01

0

2

1

1

4

0

Vibrio Fluvialis

0

0

0

0

2

0

Vibrio Hollisae

0

0

1

0.3333

3

0

Vibrio Mimicus

0

0

0

0

2

0

Vibrio, other

0

0

0

0

1

0

Vibrio Parahaemolyticus

0

1

1

0.6667

16

0

Vibrio Vulnificus

0

1

0

0.3333

13

0

Yellow Fever

0

0

0

0

0

0